Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
BridgeBio Pharma (2CL.F) Q2 2024 Earnings
2CL.F
2
May
Confirmed
Q4 2023
Q2 2024
-0.89
-0.65
-0.42
-0.19
Details
Expected EPS
-0.6867349281
Actual EPS
-0.18642000000000003
Surprise EPS
0.5
Surprise Percent
+72.85%
Description
BridgeBio Pharma (2CL.F) has reported earnings of -0.18642000000000003 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login